| A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer (NCT07543848) | Chongqing University Cancer Hospital | 2026-05-01 |
| Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. (NCT06059261) | Chongqing University Cancer Hospital | 2026-02-09 |
| Reducing Radiation Target Volume for Stage IIb Cervical Cancer (NCT07249957) | Chongqing University Cancer Hospital | 2025-11-01 |
| Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer (NCT07425795) | Chongqing University Cancer Hospital | 2025-10-10 |
| Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial (NCT07248696) | Chongqing University Cancer Hospital | 2025-10-04 |
| A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (NCT06981858) | Chongqing University Cancer Hospital | 2025-05-15 |
| Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy (NCT07217600) | Chongqing University Cancer Hospital | 2025-03-25 |
| Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial (NCT06481566) | Chongqing University Cancer Hospital | 2024-06-21 |
| A Multilevel Intervention to Improve Uptake of Gastrointestinal Cancer Screening: a Cluster Randomized Clinical Trial (NCT06830304) | Chongqing University Cancer Hospital | 2024-04-16 |
| HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China (NCT06238284) | Chongqing University Cancer Hospital | 2024-01-26 |
| A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors (NCT06055166) | Chongqing University Cancer Hospital | 2023-11-01 |
| NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma (NCT06167109) | Chongqing University Cancer Hospital | 2023-10-20 |
| The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer. (NCT05749887) | Chongqing University Cancer Hospital | 2023-08-25 |
| Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer (NCT05799469) | Chongqing University Cancer Hospital | 2023-05-01 |
| Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma (NCT05776407) | Chongqing University Cancer Hospital | 2023-05-01 |
| Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy (NCT05793749) | Chongqing University Cancer Hospital | 2023-04-01 |
| Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients (NCT06369961) | Chongqing University Cancer Hospital | 2023-03-01 |
| A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis (NCT06068387) | Chongqing University Cancer Hospital | 2023-03-01 |
| Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma (NCT05786989) | Chongqing University Cancer Hospital | 2023-02-28 |
| Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids (NCT06786780) | Chongqing University Cancer Hospital | 2023-01-01 |
| Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer (NCT05687851) | Chongqing University Cancer Hospital | 2022-12-29 |
| First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation (NCT05548348) | Chongqing University Cancer Hospital | 2022-09-26 |
| Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi (NCT05551208) | Chongqing University Cancer Hospital | 2022-08-15 |
| Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer (NCT05378087) | Chongqing University Cancer Hospital | 2022-06-27 |
| Chemotherapy Supported by Autologous Hematopoietic Stem Cells (NCT05401162) | Chongqing University Cancer Hospital | 2022-04-15 |
| Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients (NCT05401175) | Chongqing University Cancer Hospital | 2022-04-13 |
| Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer (NCT05717751) | Chongqing University Cancer Hospital | 2022-04-13 |
| The Culture of Ovarian Cancer Organoids and Drug Screening (NCT04768270) | Chongqing University Cancer Hospital | 2022-04-12 |
| The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening (NCT05290961) | Chongqing University Cancer Hospital | 2022-03-09 |
| Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells (NCT06026995) | Chongqing University Cancer Hospital | 2022-03-01 |
| A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer (NCT05779111) | Chongqing University Cancer Hospital | 2022-02-10 |
| Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids (NCT06317610) | Chongqing University Cancer Hospital | 2022-01-01 |
| The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC (NCT04830267) | Chongqing University Cancer Hospital | 2021-03-01 |
| Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC (NCT04905550) | Chongqing University Cancer Hospital | 2021-03-01 |
| The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) (NCT04555226) | Chongqing University Cancer Hospital | 2021-01-11 |
| The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer (NCT04409860) | Chongqing University Cancer Hospital | 2020-05-26 |
| Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer (NCT04395612) | Chongqing University Cancer Hospital | 2020-05-08 |
| Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test (NCT06366997) | Chongqing University Cancer Hospital | 2019-10-09 |
| Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer (NCT04542356) | Chongqing University Cancer Hospital | 2018-08-01 |